Professional Documents
Culture Documents
WHO EMRO 1st Workshop on the WHO Prequalification Programme: Priority Essential Medicines, Cairo, Egypt, 6 and 7 June, 2007
Anton Norder, MSc
Technical Officer
20 Avenue Appia CH-1211 Geneva 27 Switzerland 2 E-mail: nordera@who.int
GMP applies to both Active Pharmaceutical Ingredients (APIs) and Finished Pharmaceutical Products (FPPs)
FPP: WHO Good Manufacturing Practices for pharmaceutical products: main principles. WHO Technical Report Series, No. 908, 2003, Annex 4. API: WHO Good Manufacturing Practices: starting materials. WHO Technical Report Series, No. 823, 1992.
(ICH Q7A: Good Manufacturing Practice Guide for Active Pharmaceutical Ingredients, International Conference on Harmonization http://www.ich.org/cache/compo/276-254-1.html)
Prequalification Programme: Access to Antimalarial, Antituberculosis and Prequalification Programme: Priority Essential Medicines anti HIV/AIDS Drugs and HIV/AIDS Diagnostics of Acceptable Quality 3
1. Quality assurance 2. Good manufacturing practices for pharmaceutical products (GMP) 3. Sanitation and hygiene 4. Qualification and validation 5. Complaints 6. Product recalls 7. Contract production and analysis
Prequalification Programme: Access to Antimalarial, Antituberculosis and Prequalification Programme: Priority Essential Medicines anti HIV/AIDS Drugs and HIV/AIDS Diagnostics of Acceptable Quality 4
Items for self-inspection Self-inspection team Frequency of self-inspection Self-inspection report Follow-up action Quality audit Suppliers audits and approval
9. Personnel
General Key personnel 10. Training
Prequalification Programme: Access to Antimalarial, Antituberculosis and Prequalification Programme: Priority Essential Medicines anti HIV/AIDS Drugs and HIV/AIDS Diagnostics of Acceptable Quality 5
11. Personal hygiene 12. Premises General Ancillary areas Storage areas Weighing areas Production areas Quality control areas
13. Equipment
Prequalification Programme: Access to Antimalarial, Antituberculosis and Prequalification Programme: Priority Essential Medicines anti HIV/AIDS Drugs and HIV/AIDS Diagnostics of Acceptable Quality 6
14. Materials General Starting materials Packaging materials Intermediate and bulk products Finished products Rejected, recovered, reprocessed and reworked materials Recalled products Returned goods Reagents and culture media Reference standards Waste materials Miscellaneous
Prequalification Programme: Access to Antimalarial, Antituberculosis and Prequalification Programme: Priority Essential Medicines anti HIV/AIDS Drugs and HIV/AIDS Diagnostics of Acceptable Quality 7
15. Documentation General Documents required: Labels Testing procedures Specifications for starting and packaging materials, for intermediate and bulk products and for finished products Master formulae and Batch Processing Records Packaging instructions and Batch Packaging Records Standard Operating procedures (SOP's) and records Logbooks
Prequalification Programme: Access to Antimalarial, Antituberculosis and Prequalification Programme: Priority Essential Medicines anti HIV/AIDS Drugs and HIV/AIDS Diagnostics of Acceptable Quality 8
General Prevention of cross-contamination and bacterial contamination during production Processing operations Packaging operations
Control of starting materials and intermediate, bulk and finished products Test requirements Batch record review Stability studies
Prequalification Programme: Access to Antimalarial, Antituberculosis and Prequalification Programme: Priority Essential Medicines anti HIV/AIDS Drugs and HIV/AIDS Diagnostics of Acceptable Quality 9
Quality Management
Quality Assurance
GMP
Section 1 and 2
Prequalification Programme: Access to Antimalarial, Antituberculosis and Prequalification Programme: Priority Essential Medicines anti HIV/AIDS Drugs and HIV/AIDS Diagnostics of Acceptable Quality 10
The aspect of management function that determines and implements the quality policy The overall intention and direction regarding quality, as formally expressed and authorized by top management
Prequalification Programme: Access to Antimalarial, Antituberculosis and Prequalification Programme: Priority Essential Medicines anti HIV/AIDS Drugs and HIV/AIDS Diagnostics of Acceptable Quality 11
Quality Management
An appropriate infrastructure or quality system encompassing the organization structure, procedures, processes and resources The systematic actions necessary to ensure adequate confidence that a product (or service) will satisfy given requirements for Quality
Prequalification Programme: Access to Antimalarial, Antituberculosis and Prequalification Programme: Priority Essential Medicines anti HIV/AIDS Drugs and HIV/AIDS Diagnostics of Acceptable Quality 12
Premises
Primary materials People Procedures Processes defined and recorded
Prequalification Programme: Access to Antimalarial, Antituberculosis and Prequalification Programme: Priority Essential Medicines anti HIV/AIDS Drugs and HIV/AIDS Diagnostics of Acceptable Quality 13
Quality Assurance
They are described on the following slides in order to emphasize their relationship and their fundamental importance to the production and control of pharmaceutical products
1.1
Prequalification Programme: Access to Antimalarial, Antituberculosis and Prequalification Programme: Priority Essential Medicines anti HIV/AIDS Drugs and HIV/AIDS Diagnostics of Acceptable Quality 14
Quality Assurance
Wide-ranging concept covers all matters that individually or collectively influence the quality of a product
Totality of the arrangements to ensure that the drug is continuously of the right quality for the intended use Quality Assurance incorporates GMP and also includes product design and development, with special focus on process design
1.1
Prequalification Programme: Access to Antimalarial, Antituberculosis and Prequalification Programme: Priority Essential Medicines anti HIV/AIDS Drugs and HIV/AIDS Diagnostics of Acceptable Quality 15
The position of QA
Director
QA
Production QC lab Other Depts
Prequalification Programme: Access to Antimalarial, Antituberculosis and Prequalification Programme: Priority Essential Medicines anti HIV/AIDS Drugs and HIV/AIDS Diagnostics of Acceptable Quality 16
Products are designed and developed correctly Complying with, e.g. GMP, GCP, GLP Production and control operations are defined Managerial responsibilities are defined In job descriptions The manufacture, supply and use of correct starting and packaging materials
1.1 a- d
Prequalification Programme: Access to Antimalarial, Antituberculosis and Prequalification Programme: Priority Essential Medicines anti HIV/AIDS Drugs and HIV/AIDS Diagnostics of Acceptable Quality 17
Controls are performed, including intermediates, bulk, calibration and validation Correct processing and checking of the finished product Products are sold/supplied only after review by the authorized person Complying with marketing authorization, production and QC requirements Proper storage, distribution and handling
1.1 e - h
Prequalification Programme: Access to Antimalarial, Antituberculosis and Prequalification Programme: Priority Essential Medicines anti HIV/AIDS Drugs and HIV/AIDS Diagnostics of Acceptable Quality 18
Prequalification Programme: Access to Antimalarial, Antituberculosis and Prequalification Programme: Priority Essential Medicines anti HIV/AIDS Drugs and HIV/AIDS Diagnostics of Acceptable Quality 19
Responsibility of the Manufacturer for the quality of the product Fit for intended use Comply with marketing authorization Safety, efficacy and quality Commitment of senior management and involvement of all staff Comprehensively designed and well implemented quality system Full documentation and monitoring of effectiveness Competent personnel, sufficient premises, equipment and facilities
1.3
Prequalification Programme: Access to Antimalarial, Antituberculosis and Prequalification Programme: Priority Essential Medicines anti HIV/AIDS Drugs and HIV/AIDS Diagnostics of Acceptable Quality 20
That part of QA that ensures that products are consistently produced and controlled Quality standards Marketing authorization Aim: Diminishing risks that cannot be controlled by testing of product Contamination and cross-contamination Mix-ups (confusion)
2.1
Prequalification Programme: Access to Antimalarial, Antituberculosis and Prequalification Programme: Priority Essential Medicines anti HIV/AIDS Drugs and HIV/AIDS Diagnostics of Acceptable Quality 21
18 8 5 3 1.6 1.2 2 4
10
1.4
Code & Debug
Prequalification Programme: Access to Antimalarial, Antituberculosis and Prequalification Programme: Priority Essential Medicines anti HIV/AIDS Drugs and HIV/AIDS Diagnostics of Acceptable Quality 22
2.1 a - c
Prequalification Programme: Access to Antimalarial, Antituberculosis and Prequalification Programme: Priority Essential Medicines anti HIV/AIDS Drugs and HIV/AIDS Diagnostics of Acceptable Quality 23
(cont'd)
Clear, written instructions and procedures Trained operators Records of actions, deviations and investigations Records for manufacture and distribution Proper storage and distribution Systems for complaints and recalls
2.1 d - j
Prequalification Programme: Access to Antimalarial, Antituberculosis and Prequalification Programme: Priority Essential Medicines anti HIV/AIDS Drugs and HIV/AIDS Diagnostics of Acceptable Quality 24
Self-inspection
Prequalification Programme: Access to Antimalarial, Antituberculosis and Prequalification Programme: Priority Essential Medicines anti HIV/AIDS Drugs and HIV/AIDS Diagnostics of Acceptable Quality 25
The senior management is responsible to attain the company's quality objectives All different departments and all levels within departments should be involved; and it's the senior management who should facilitate this Also suppliers and distributors should be involved The senior management should make available the required resources The basis of the quality system is the quality statement and quality policy, by the senior management
Prequalification Programme: Access to Antimalarial, Antituberculosis and Prequalification Programme: Priority Essential Medicines anti HIV/AIDS Drugs and HIV/AIDS Diagnostics of Acceptable Quality 26
To review and verify the consistency and appropriateness of the existing process
To identify and highlight any trends in the process, e.g. in analytical results, yields etc.
To identify any possible product or process improvements
Not yet mandatory in WHO GMP, but it is likely to become mandatory like it is in other GMP's
Prequalification Programme: Access to Antimalarial, Antituberculosis and Prequalification Programme: Priority Essential Medicines anti HIV/AIDS Drugs and HIV/AIDS Diagnostics of Acceptable Quality 27
Review of starting materials/ packaging materials, esp from new sources Review of in-process control results and finished product analytical control results Amount of batches and packaging units produced and their yields Reviews of: Out-of-spec situations Rejections Deviations Changes Plus their investigations as well as a trend analysis of causes
Prequalification Programme: Access to Antimalarial, Antituberculosis and Prequalification Programme: Priority Essential Medicines anti HIV/AIDS Drugs and HIV/AIDS Diagnostics of Acceptable Quality 28
Review of Marketing Authorization variations submitted, granted or refused (incl. third countries)
Review of stability monitoring programme and its trends Review of adequacy of previous decisions on changes or improvements or corrective actions For new Marketing Authorizations (plus new variations) a review of post marketing commitment The qualification status of all relevant equipment and utilities (like water, HVAC, gases, etc.) Review of Technical Agreements (if applicable), to verify they are upto-date.
Prequalification Programme: Access to Antimalarial, Antituberculosis and Prequalification Programme: Priority Essential Medicines anti HIV/AIDS Drugs and HIV/AIDS Diagnostics of Acceptable Quality 29
Complaints handling
Complaints: Principle
All complaints and other information concerning potentially defective products must be carefully reviewed according to written procedures and corrective action should be taken.
5.1
Prequalification Programme: Access to Antimalarial, Antituberculosis and Prequalification Programme: Priority Essential Medicines anti HIV/AIDS Drugs and HIV/AIDS Diagnostics of Acceptable Quality 30
Complaints Procedure:
Designated responsible person: To handle complaint Decide on measure to be taken May be authorized person - if not, must advise authorized person of results Sufficient support staff Access to records Written procedure (SOP): Describes action to be taken Includes need to consider a recall (e.g. possible product defect)
5.2 5.3
Prequalification Programme: Access to Antimalarial, Antituberculosis and Prequalification Programme: Priority Essential Medicines anti HIV/AIDS Drugs and HIV/AIDS Diagnostics of Acceptable Quality 31
Thorough investigation: QC involved With special attention to establish whether "counterfeiting" may have been the cause Fully recorded investigation reflect all the details
Due to product defect (discovered or suspected): Consider checking other batches Batches containing reprocessed product
5.4 5.6
Prequalification Programme: Access to Antimalarial, Antituberculosis and Prequalification Programme: Priority Essential Medicines anti HIV/AIDS Drugs and HIV/AIDS Diagnostics of Acceptable Quality 32
Investigation and evaluation should result in appropriate followup actions May include a "recall" All decisions and measures taken should be recorded Referenced in batch records Records reviewed - trends and recurring problems
5.7 5.9
Prequalification Programme: Access to Antimalarial, Antituberculosis and Prequalification Programme: Priority Essential Medicines anti HIV/AIDS Drugs and HIV/AIDS Diagnostics of Acceptable Quality 33
Inform competent authorities in case of serious quality problems such as: Faulty manufacture 5.10 Product deterioration Counterfeiting Have a thorough recall procedure that is fitting completely to the complaints handling procedure Keep track on trends in complaints, their investigations and results
Prequalification Programme: Access to Antimalarial, Antituberculosis and Prequalification Programme: Priority Essential Medicines anti HIV/AIDS Drugs and HIV/AIDS Diagnostics of Acceptable Quality 34
Self-Inspection
Purpose is to evaluate whether a companys operations remain compliant with GMP
The programme should cover all aspects of production and quality control be designed to detect shortcomings in the implementation of GMP recommend corrective actions set a timetable for corrective action to be completed Be performed routinely Also on special occasions such as Recalls Repeated rejections When a GMP inspection is announced by the national drug regulatory authority 8.1
Prequalification Programme: Access to Antimalarial, Antituberculosis and Prequalification Programme: Priority Essential Medicines anti HIV/AIDS Drugs and HIV/AIDS Diagnostics of Acceptable Quality 35
Self-Inspection (cont'd)
The Self-Inspection Team
Team appointed by management, with: authority sufficient experience, expertise in their own field. knowledge of GMP may be from inside or outside the company Frequency should normally be at least once a year May depend on company requirements Size of the company and activities
8.3, 8.4
Prequalification Programme: Access to Antimalarial, Antituberculosis and Prequalification Programme: Priority Essential Medicines anti HIV/AIDS Drugs and HIV/AIDS Diagnostics of Acceptable Quality 36
Self-Inspection (cont'd)
Carrying out a Self-Inspection
Report prepared at completion of inspection, including: results evaluation conclusions recommended corrective measures Follow-up action Effective follow-up programme Company management to evaluate both the report and corrective actions
8.5, 8.6
Prequalification Programme: Access to Antimalarial, Antituberculosis and Prequalification Programme: Priority Essential Medicines anti HIV/AIDS Drugs and HIV/AIDS Diagnostics of Acceptable Quality 37
GMP is mandatory in countries with a regulated pharmaceutical market, and in the WHO Prequalification Programme too. GMP's are very similar, they are nothing but Good Common Sense
Good Practices cover all aspects of company's activities prior to sales GMP is not a reward, nor an external assignment, it should be built into the company Just like quality, which should be built into the product The role and involvement of senior management is crucial GMP means an urge for continuous improvement, 3 of the tools to do so are:
Prequalification Programme: Access to Antimalarial, Antituberculosis and Prequalification Programme: Priority Essential Medicines anti HIV/AIDS Drugs and HIV/AIDS Diagnostics of Acceptable Quality 38
http://www.who.int/prequal
Prequalification Programme: Access to Antimalarial, Antituberculosis and Prequalification Programme: Priority Essential Medicines anti HIV/AIDS Drugs and HIV/AIDS Diagnostics of Acceptable Quality 39